Technical Trend Shifts and Moving Averages
After a prolonged sideways trend, Viyash Scientific’s technical trend has transitioned to mildly bullish territory. This shift is supported by the daily moving averages, which currently indicate a bullish stance. The stock price has moved above key short-term moving averages, suggesting strengthening upward momentum. The daily moving averages’ bullish signal is a positive indicator for traders looking for confirmation of a trend reversal.
However, the weekly and monthly moving averages present a more nuanced picture. While the monthly moving averages align with a bullish outlook, weekly indicators remain cautious, reflecting the stock’s recent volatility and the need for sustained momentum to confirm a longer-term uptrend.
MACD and Momentum Oscillators
The Moving Average Convergence Divergence (MACD) indicator presents a mixed scenario. On a weekly basis, the MACD remains mildly bearish, indicating some short-term selling pressure or consolidation. Conversely, the monthly MACD has turned bullish, signalling that the longer-term momentum is improving. This divergence between weekly and monthly MACD readings suggests that while short-term traders may face some resistance, the broader trend is gaining strength.
Complementing the MACD, the KST (Know Sure Thing) indicator remains bearish on a weekly scale and mildly bearish monthly, reinforcing the cautious stance in the near term. These oscillators highlight the importance of monitoring momentum closely before committing to a strong bullish bias.
RSI and Bollinger Bands Analysis
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This indicates that the stock is neither overbought nor oversold, providing room for further price movement in either direction without immediate risk of reversal due to extreme conditions.
Meanwhile, Bollinger Bands on weekly and monthly timeframes are bullish, suggesting that price volatility is expanding upwards and the stock is breaking out of previous trading ranges. The upper band expansion often signals increased buying interest and potential for further gains, which aligns with the recent price surge to ₹210.00.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Volume and On-Balance Volume (OBV) Insights
On-Balance Volume (OBV) analysis reveals a mildly bearish trend on the weekly chart, indicating that volume flow has not yet fully confirmed the recent price gains. The monthly OBV shows no clear trend, suggesting that volume participation remains uncertain over the longer term. This divergence between price and volume highlights the need for caution, as sustained volume support is critical for validating the bullish momentum.
Dow Theory and Broader Market Context
According to Dow Theory, both weekly and monthly signals remain mildly bearish. This suggests that despite recent price improvements, the broader market sentiment and sectoral trends may still be exerting downward pressure on the stock. Investors should weigh these signals carefully against the company’s individual technical improvements.
Price Performance Relative to Sensex
Viyash Scientific’s price performance has outpaced the Sensex across several key periods, underscoring its relative strength. Over the past week, the stock returned 8.75%, compared to the Sensex’s 6.06%. Over one month, the stock gained 3.45% while the Sensex declined by 1.72%. Year-to-date, Viyash Scientific is up 0.89%, contrasting with the Sensex’s 8.99% decline.
Longer-term returns are even more impressive, with a 53.45% gain over one year versus the Sensex’s 4.49%, and a remarkable 180.71% over three years compared to the Sensex’s 29.63%. However, the stock has underperformed over five years, with a negative 21.92% return against the Sensex’s 55.92%, and over ten years, it has delivered 25.90% compared to the Sensex’s 214.35%. These figures reflect the stock’s volatility and cyclical nature within the Pharmaceuticals & Biotechnology sector.
Valuation and Mojo Score Update
MarketsMOJO has upgraded Viyash Scientific’s Mojo Grade from Sell to Hold as of 8 Apr 2026, reflecting improved technical and fundamental conditions. The current Mojo Score stands at 56.0, indicating a moderate outlook. The company remains classified as a small-cap, which entails higher risk but also potential for significant upside if momentum sustains.
Holding Viyash Scientific Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Key Price Levels and Volatility
On 9 Apr 2026, Viyash Scientific traded within a range of ₹198.70 to ₹210.00, closing at the day’s high. This intraday strength is a positive sign, indicating strong buying interest. The stock remains well below its 52-week high of ₹260.30 but comfortably above its 52-week low of ₹111.00, suggesting a recovery phase.
Investors should monitor whether the stock can sustain above the current levels and break through resistance near ₹220-₹230 to confirm a more robust bullish trend. Failure to hold above the daily moving averages or a reversal in weekly momentum indicators could signal renewed weakness.
Conclusion: A Cautious Optimism
Viyash Scientific Ltd’s recent technical parameter changes point to a cautiously optimistic outlook. The shift from sideways to mildly bullish trend, supported by daily moving averages and monthly MACD, suggests the stock is attempting to build sustainable momentum. However, mixed signals from weekly oscillators, Dow Theory, and volume indicators counsel prudence.
For investors, the current Mojo Grade of Hold reflects this balanced view. The stock’s strong relative performance against the Sensex over shorter and medium terms is encouraging, but the long-term underperformance and small-cap status warrant careful position sizing and monitoring.
Overall, Viyash Scientific appears poised for a potential uptrend, provided it can maintain technical support and volume confirmation. Market participants should watch key technical levels and broader sector trends closely to gauge the sustainability of this momentum shift.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
